150 related articles for article (PubMed ID: 32151463)
1. Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine.
Yu H; Karunakaran KP; Jiang X; Chan Q; Rose C; Foster LJ; Johnson RM; Brunham RC
Vaccine; 2020 Apr; 38(16):3280-3291. PubMed ID: 32151463
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice.
Yu H; Karunakaran KP; Jiang X; Brunham RC
Vaccine; 2014 Aug; 32(36):4672-80. PubMed ID: 24992718
[TBL] [Abstract][Full Text] [Related]
3. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.
Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC
Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.
Pal S; Favaroni A; Tifrea DF; Hanisch PT; Luczak SET; Hegemann JH; de la Maza LM
Vaccine; 2017 May; 35(19):2543-2549. PubMed ID: 28385608
[TBL] [Abstract][Full Text] [Related]
6. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ T cells.
Yu H; Jiang X; Shen C; Karunakaran KP; Jiang J; Rosin NL; Brunham RC
Infect Immun; 2010 May; 78(5):2272-82. PubMed ID: 20231405
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.
Yu H; Karunakaran KP; Jiang X; Shen C; Andersen P; Brunham RC
Infect Immun; 2012 Apr; 80(4):1510-8. PubMed ID: 22290151
[TBL] [Abstract][Full Text] [Related]
9. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
Vasilevsky S; Stojanov M; Greub G; Baud D
Virulence; 2016; 7(1):11-22. PubMed ID: 26580416
[TBL] [Abstract][Full Text] [Related]
10. Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
Tifrea DF; Pal S; Popot JL; Cocco MJ; de la Maza LM
J Immunol; 2014 Jun; 192(11):5201-13. PubMed ID: 24778450
[TBL] [Abstract][Full Text] [Related]
11. Protection Against Chlamydia trachomatis Infection and Upper Genital Tract Pathological Changes by Vaccine-Promoted Neutralizing Antibodies Directed to the VD4 of the Major Outer Membrane Protein.
Olsen AW; Follmann F; Erneholm K; Rosenkrands I; Andersen P
J Infect Dis; 2015 Sep; 212(6):978-89. PubMed ID: 25748320
[TBL] [Abstract][Full Text] [Related]
12. The
Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2018; 9():2369. PubMed ID: 30374357
[TBL] [Abstract][Full Text] [Related]
13. A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.
Pal S; Tatarenkova OV; de la Maza LM
Immunology; 2015 Nov; 146(3):432-43. PubMed ID: 26423798
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of Recombinant MOMP in Extended-Releasing PLGA 85:15 Nanoparticles Confer Protective Immunity Against a
Sahu R; Dixit S; Verma R; Duncan SA; Smith L; Giambartolomei GH; Singh SR; Dennis VA
Front Immunol; 2021; 12():660932. PubMed ID: 33936096
[TBL] [Abstract][Full Text] [Related]
16. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach.
Li W; Guentzel MN; Seshu J; Zhong G; Murthy AK; Arulanandam BP
Clin Vaccine Immunol; 2007 Dec; 14(12):1537-44. PubMed ID: 17942608
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cells and antibody are required for optimal major outer membrane protein vaccine-induced immunity to Chlamydia muridarum genital infection.
Farris CM; Morrison SG; Morrison RP
Infect Immun; 2010 Oct; 78(10):4374-83. PubMed ID: 20660610
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation.
Hepler RW; Nahas DD; Lucas B; Kaufhold R; Flynn JA; Galli JD; Swoyer R; Wagner JM; Espeseth AS; Joyce JG; Cook JC; Durr E
Protein Sci; 2018 Nov; 27(11):1923-1941. PubMed ID: 30144190
[TBL] [Abstract][Full Text] [Related]
19. Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology.
O'Meara CP; Armitage CW; Andrew DW; Kollipara A; Lycke NY; Potter AA; Gerdts V; Petrovsky N; Beagley KW
Vaccine; 2017 Jul; 35(31):3883-3888. PubMed ID: 28602608
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
Su H; Parnell M; Caldwell HD
Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
